Moderna seeks U.S. authorization of COVID-19 vaccine boosters for all adults By Reuters

© Reuters. FILE PHOTO: An employee shows the Moderna COVID-19 vaccine at Northwell Health’s Long Island Jewish Valley Stream hospital in New York, U.S., December 21, 2020. REUTERS/Eduardo Munoz

(Reuters) – Moderna (NASDAQ:) Inc said on Wednesday it had applied with the U.S. Food and Drug Administration for authorization of its COVID-19 booster vaccine for all adults aged 18 and older.

The FDA has cleared booster shots of COVID-19 vaccines for people who are immunocompromised, those aged 65 and older and for individuals at high risk of severe disease or who are regularly exposed to the virus.

Pfizer Inc (NYSE:) last week applied for a similar clearance for the booster doses of the vaccine it has developed with German partner BioNTech.

A U.S. Centers for Disease Control and Prevention (CDC) advisory panel will meet on Friday to discuss expanding the eligibility for booster doses of the Pfizer vaccine.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*